Dihydroxyaluminum Sodium Carbonate

57 interactions

Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 10, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Ketoconazole Topical Cabotegravir Cefuroxime Deferasirox Octreotide Injection Erdafitinib

15 Major 34 Moderate 8 Minor

All (57) Major (15) Moderate (34) Minor (8)

Major

Dihydroxyaluminum Sodium Carbonate Acalabrutinib Calquence Reduced acalabrutinib exposure Details Dihydroxyaluminum Sodium Carbonate Cabotegravir Apretude Reduced cabotegravir plasma concentrations Details Dihydroxyaluminum Sodium Carbonate Cefuroxime Ceftin® Decreased cefuroxime axetil exposure Details Dihydroxyaluminum Sodium Carbonate Deferasirox Exjade Decreased deferasirox effectiveness Details Dihydroxyaluminum Sodium Carbonate Digoxin Cardoxin® Reduced digoxin exposure Details Dihydroxyaluminum Sodium Carbonate Erdafitinib Balversa Altered serum phosphate levels Details Dihydroxyaluminum Sodium Carbonate Ezetimibe Zetia Reduced ezetimibe exposure Details Dihydroxyaluminum Sodium Carbonate Gefitinib Iressa Decreased exposure of gefitinib Details Dihydroxyaluminum Sodium Carbonate Hydroxychloroquine Plaquenil Reduced hydroxychloroquine exposure Details Dihydroxyaluminum Sodium Carbonate Infigratinib Truseltiq Decreased infigratinib plasma concentrations Details Dihydroxyaluminum Sodium Carbonate Ketoconazole Topical Extina® Foam Reduced ketoconazole exposure and reduced efficacy of ketoconazole Details Dihydroxyaluminum Sodium Carbonate Mefenamic Acid Ponstel® Increased exposure to mefenamic acid Details Dihydroxyaluminum Sodium Carbonate Neratinib Nerlynx Decreased neratinib exposure Details Dihydroxyaluminum Sodium Carbonate Octreotide Bynfezia Decreased octreotide bioavailability Details Dihydroxyaluminum Sodium Carbonate Octreotide Injection Bynfezia Decreased octreotide bioavailability Details

Moderate

Dihydroxyaluminum Sodium Carbonate Aspirin Acuprin® Decreased salicylate effectiveness Details Dihydroxyaluminum Sodium Carbonate Aspirin Rectal Aspirin Decreased salicylate effectiveness Details Dihydroxyaluminum Sodium Carbonate Bosutinib Bosulif Reduced bosutinib exposure Details Dihydroxyaluminum Sodium Carbonate Captopril Capoten® Decreased captopril effectiveness Details Dihydroxyaluminum Sodium Carbonate Cefdinir Omnicef® Decreased cefdinir efficacy Details Dihydroxyaluminum Sodium Carbonate Cefpodoxime Banan® Decreased cefpodoxime effectiveness Details Dihydroxyaluminum Sodium Carbonate Chloroquine Aralen® Decreased efficacy of chloroquine Details Dihydroxyaluminum Sodium Carbonate Dasatinib Phyrago Reduced dasatinib exposure Details Dihydroxyaluminum Sodium Carbonate Deflazacort Emflaza Decreased deflazacort effectiveness Details Dihydroxyaluminum Sodium Carbonate Demeclocycline Declomycin® Reduced efficacy of tetracyclines Details Dihydroxyaluminum Sodium Carbonate Doxycycline Injection Acticlate Reduced efficacy of tetracyclines Details Dihydroxyaluminum Sodium Carbonate Erlotinib Tarceva Reduced erlotinib exposure Details Dihydroxyaluminum Sodium Carbonate Ethambutol Myambutol Decreased ethambutol serum concentrations Details Dihydroxyaluminum Sodium Carbonate Fexofenadine Allegra Decreased fexofenadine efficacy Details Dihydroxyaluminum Sodium Carbonate Folic Acid Folacin Reduced folic acid exposure and reduced efficacy of folic acid Details Dihydroxyaluminum Sodium Carbonate Gatifloxacin Ophthalmic Zymar® Loss of gatifloxacin efficacy Details Dihydroxyaluminum Sodium Carbonate Gemifloxacin Factive Decreased oral gemifloxacin effectiveness Details Dihydroxyaluminum Sodium Carbonate Ibandronate Boniva Decreased ibandronate effectiveness Details Dihydroxyaluminum Sodium Carbonate Ibandronate Injection Boniva Decreased ibandronate effectiveness Details Dihydroxyaluminum Sodium Carbonate Levofloxacin Levaquin Decreased oral levofloxacin effectiveness Details Dihydroxyaluminum Sodium Carbonate Levofloxacin Injection Levaquin Decreased oral levofloxacin effectiveness Details Dihydroxyaluminum Sodium Carbonate Levothyroxine Ermeza Reduced efficacy of levothyroxine Details Dihydroxyaluminum Sodium Carbonate Mesalamine Apriso Alteration of mesalamine bioavailability Details Dihydroxyaluminum Sodium Carbonate Mesalamine Rectal Canasa Alteration of mesalamine bioavailability Details Dihydroxyaluminum Sodium Carbonate Minocycline Amzeeq Reduced efficacy of minocycline Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist

Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.